← SynDRA
TRICIRIBINE
SynDRA canonical compound SYN0004308 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | AKT2 |
| Mechanism of action | Akt inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- NSC154020
- Akt Inhibitor V, Triciribine
- MLS002702033
- Akt/PKB Signaling Inhibitor-2
- NSC-154020
- TCN
- Akt inhibitor V
- AC1Q7CGY
- AC1L6DVE
- tricyclic nucleoside (TCN)
- SCHEMBL61269
- GTPL5920
- CHEMBL1892348
- CHEBI:91697
- HMS3268N05
- HMS3654C06
- HMS3229A09
- HSCI1_000386
- CCG-206732
- 5-methyl-1-pentofuranosyl-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine
- SMR001565606
- SC-89664
- NCI60_001091
- Akt/protein kinase B signaling inhibitor-2
- BRD-A42649439-001-01-0
- BRD-A42649439-001-02-8
- 1,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dih
- API-2
- Tricyclic nucleoside
- Pentaazacentopthylene
- Triciribine [INN]
- Tricirbine
- BRN 1171593
- 1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine
- CHEBI:65310
- 2421HMY9N6
- 1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-
Look up TRICIRIBINE in the interactive SynDRA portal →